Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study

Atopic Dermatitis

The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study

Br J Dermatol

Ivert LU, Anveden-Berglind I, Gembert K, Eriksson J, Giunta DH, Hägg D, Linder M

doi: 10.1093/bjd/ljaf418

Atopic Dermatitis

The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study

J Eur Acad Dermatol Venereol

Kridin K, Abdelghaffar M, Bieber K, Thaci D, Ludwig RJ

doi: 10.1111/jdv.20724

Atopic Dermatitis

Decreased Risk of Reduced Linear Growth Among Children with Atopic Dermatitis Receiving Dupilumab: A Cohort Study

J Am Acad Dermatol

Chen TL, Ma SH, Ou WF, Chen CC, Wu CY

doi: 10.1016/j.jaad.2025.08.020

Autoimmune Disease

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: A Danish cohort study

Rheumatology (Oxford)

Loiseau P, Mailhac A, Duhaut P, Thomsen RW

doi: 10.1093/rheumatology/keaf210

Atopic Dermatitis

Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study

Acta Derm Venereol

Schlösser AR, Caron AGM, Den Ouden MS, Baart SJ, Gerbens LAA, Spuls PI, Nijsten TEC, Schappin R, Hijnen D

doi: 10.2340/actadv.v105.44165

Psoriasis

GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study

Br J Dermatol

Olbrich H, Kridin K, Zirpel H, Hernandez G, Sadik CD, Gaffal E, Thaçi D, Ludwig RJ

doi: 10.1093/bjd/ljaf346

Systemic Lupus Erythematosus

Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study

Rheumatology (Oxford)

Kharouf F, Mehta P, Li Q, Gladman DD, Whittall Garcia LP, Touma Z

doi: 10.1093/rheumatology/keaf464

Atopic Dermatitis

Examining the Impact of Child Atopic Dermatitis on Maternal Depression: A Longitudinal Cohort Study

J Am Acad Dermatol

Kang HE, Lee A, Wang SP, Ye M, Capozza K, Ellis AW, Fox A, LeWinn KZ, Abuabara K

doi: 10.1016/j.jaad.2025.10.019

Melanoma and Skin Cancer

Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study

J Am Acad Dermatol

Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Shankar Ramesh Kumar SK, Kundu RV, Kundu SD

doi: 10.1016/j.jaad.2026.02.035

Related content

The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study

The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study

Decreased Risk of Reduced Linear Growth Among Children with Atopic Dermatitis Receiving Dupilumab: A Cohort Study

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: A Danish cohort study

Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study

GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study

Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study

Examining the Impact of Child Atopic Dermatitis on Maternal Depression: A Longitudinal Cohort Study

Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study